Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02639234
Title Vigil + Nivolumab in Advanced Non-Small Cell Lung Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gradalis, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Texas Oncology, P.A., Texas Cancer Center Abilene Texas 79606 United States Details
Mary Crowley Cancer Research Centers Dallas Texas 75230 United States Details
Cancer Care Northwest Spokane Valley Washington 99216 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field